Controlling Drug Prices Shouldn’t Harm Rare Disease Patient Access to Treatment
geralt / Pixabay

Controlling Drug Prices Shouldn’t Harm Rare Disease Patient Access to Treatment

According to a story from The Globe and Mail, Canada's Patented Medicine Prices Review Board announced last month that drug prices would be subject to new regulations. These new rules…

Continue Reading Controlling Drug Prices Shouldn’t Harm Rare Disease Patient Access to Treatment

Biomedical Innovation Law Expert Presents Ethical Difficulties Posed by Gene Editing

According to a publication from Charcot Marie Tooth News, biomedical law expert Timo Minssen recently gave a presentation at the New York Genome Center where he discussed the potential ethical…

Continue Reading Biomedical Innovation Law Expert Presents Ethical Difficulties Posed by Gene Editing

The Power of Collective Action in Providing Insurance Coverage for Spinal Muscular Atrophy Gene Therapy

Maisie Green Maisie Green is a 20-month-old little girl whose insurance has finally approved coverage for a life-altering spinal muscular atrophy treatment. Two weeks ago she received the singular infusion…

Continue Reading The Power of Collective Action in Providing Insurance Coverage for Spinal Muscular Atrophy Gene Therapy
Close Menu